Company news
Caribou Biosciences, Inc. news in 2025
Caribou Biosciences, Inc.'s news releases, calls and decks from 2025, newest first.
Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025
December 1, 2025
Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
November 12, 2025
Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies
November 3, 2025
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
November 3, 2025
Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma
November 2, 2025
Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference
August 25, 2025
Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update
August 12, 2025
Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference
May 28, 2025
Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update
May 8, 2025
Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference
May 6, 2025
Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs
April 24, 2025
Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 10, 2025
Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025
January 11, 2025
Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer
January 1, 2025